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Abstract
• Hepatocellular carcinoma (HCC) is a leading cause of 
cancer-related death in world wide.
• TD26 =            tumor size
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Abstract
was highly expressed in HCC tumor
increased lipogenesis in HCC cells
promoted HCC cell proliferation and 
tumor growth
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expressed :
 in liver
 white adipose
 brown adipose tissues
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TD26
is a novel but atypical ANGPTL family member
promotes ANGPTL3 cleavage
Introduction
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Introduction
Hepatocellular Carcinoma
 the most common primary malignancy 
of liver cancer
 sixth most common cancer
 second leading cause of cancer-related 
death worldwide due to its poor 
prognosis
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Introduction
• Sorafenib is the first-line treatment for advanced HCC
• Sorafenib VEGFR, PDGFR and Raf
• In HCC  patients the responsive rate to sorafenib
remains low.
• oncogenic pathways: , and 
• aberrant lipogenesis cause to cancer
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Introduction
increased lipid biosynthesis has 
been reported to promote HCC
transcriptional master 
regulator 
promoting cancer cell 
growth and metastasis
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Introduction
SREBPs                              helix-loop-helix–leucine zipper
SREBP1
SREBP2
expression genes involved in 
biosynthesis of lipid and cholesterol.
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SREBPs
inactive
S1P
S2P
mature SREBPs
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Introduction
synthesis
cholesterol,FA, triglycerides
cholesterol 
FASN
SCD1
ACC1
ACLY
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cell proliferation in varieties of human cancers
activated by the oncogenic AKT-mTORC1 signaling 
pathway
positively correlate with tumor size and tumor-node 
metastasis tumor suppressor AMPK
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C-terminus (aa from 121 to 198) TD26
nuclear SREBP1
AMPK
Lipogenesis
tumor cell 
proliferation
tumor progression
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Material and methods
Material and methods
samples          56 of primary HCC tumor tissues
were               56  of matched normal tissues 
collected         96 HCC tumor
Renji Hospital School of Medicine, Shanghai Jiaotong
University.
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Material and methods
56 of primary HCC tumor tissues
56 of matched normal tissues 
96 HCC tumor
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Material and methods
Samples
were 
collected
56 of primary HCC tumor tissues
56  of matched normal tissues
96 HCC tumor samples
Shanghai Eastern Hepatobiliary Surgery Hospital
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Cell lines and cell culture
SMMC-7721
HepG2
Huh-7
SUN-449
SUN-387 
MHCC-97L
MHCC-97H
Hep3B,
HEK 293T
DMEM with 10% FBS
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Xenograft studies in nude mice
BALB/c (nu/nu) 
mice
6- week 
1.0×106 
tumor cells
The harvested tumors were:
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Quantitative PCR
Total RNA was extracted using Trizol kit (Invitrogen)
cDNA with a cDNA Synthesis kit (Takara, Japan)
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Quantitative PCR
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Mass Spectrometry
using an HPLC 
system
mass 
spectrometer
and
tumor 
cells
1.5 ml chl & 
meth(2/1)
Vortex 1 min
3000 rpm 
10 min
cell
800ul
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200 ul isopropanol / methanol supernatant
Triglyceride and cholesterol assays
 Intracellular triglyceride levels were measured using a triglyceride 
assay kit (Nanjing Jiancheng Bioengineering Institute, China)
 Intracellular cholesterols were detected using a cholesterol 
assay kit (Nanjing Jiancheng Bioengineering Institute, China).
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Luciferase reporter assays
SREBP1 
reporter 
vector
[luciferase P]
24h
cell lysates were analyzed using the 
Dual-luciferase reporter assay 
kit(Promega,USA)
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Coimmunoprecipitation
Cells 
harvested 
lysed in IP lysis buffer (Thermo Fisher, Inc)
protease inhibitor cocktail (Merck Millipore, Germany)
4°C
30 min at 
4°C 
centrifuge 
at full 
speed
Extracts 
of 
proteins
antibodies
Incubated
for 24h 
at 4°C Pr
+
Ab
Protein A/G 
(Pierce)
4°C
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Coimmunoprecipitation
5 wash
(15 min/time)
with IP lysis
buffer
SDS-PAGE 
&
Western Blot
Pr+Ab+
Pr A/G
Primary antibodies:
 anti-TD26(Biolegend)
 anti-SREBP1
(Santa Cruz)
 anti-AMPK 
(Santa Cruz),
 anti-IgG (Abcam)
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Results
Results
TD26 is upregulated in HCC tissues and is a poor prognostic 
marker in HCC
TD26 promotes HCC cell proliferation in vitro
qPCR and western blot assays showed TD26 expression:
in HepG2 & Huh7 
in SMMC-7721 & MHCC-97L cells
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Results
TD26 promotes HCC tumor growth in vivo
TD26 positively correlates with lipogenesis in HCC cells and tissues
TD26 enhances SREBP1 transactivity by increasing the nuclear form 
of SREBP1(nSREBP1)
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Results
TD26 interacts with nSREBP1 to block AMPK
TD26 interacting with nSREBP1 is essential for TD26 mediated 
tumor progression in HCC cells
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Discussion
Discussion
TD26 is highly expressed in HCC tumor tissues
•TD26 is positively correlated with tumor size
TD26 increases HCC cell proliferation and 
tumor growth by enhancing SREBP1-
dependent lipogenesis
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Discussion
TD26 can negatively regulate NF-kB
•Western blot and ELISA assays showed that 
thesecretory signal peptide is not required 
for TD26 expression but is essential for 
secretion of TD26
These findings indicate that TD26 can function 
intracellularly independent its secretory feature.
39
Discussion
Several studies have reported increased TD26 
levels in obesity and/or diabetes patients
•recent study indicates increased TD26 levels 
in cirrhosis patients
diabetes, obesity and cirrhosis are risk factors 
for HCC, it is conceivable that TD26 may play a 
role in HCC development
•SREBP1 should be a promising therapeutic 
target of cancer 40
Discussion
AKT-mTORC1 signaling pathway
SREBP1 AMPK
we demonstrate that TD26 is a novel positive regulator of 
SREBP1 in HCC by interacting with SREBP1 to compete AMPK.
C-terminal TD26 may play a major role in modulating TD26-mediated 
increase of lipogenesis and cell proliferation in HCC.
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